Hot Features
プレミアム
Ikena Oncology Inc (IKNA)
NASDAQ
登録してリアルタイムのチャート、分析ツール、価格を入手してください。
Ikena Oncology Inc is a targeted oncology company developing precision medicines tailored to biomarker-defined patient groups with specific unmet needs. Its lead targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD... Ikena Oncology Inc is a targeted oncology company developing precision medicines tailored to biomarker-defined patient groups with specific unmet needs. Its lead targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, transcription factor in the Hippo signaling pathway. The Hippo pathway is genetically altered in approximately 10% of human cancers and is widely accepted as a prevalent driver of cancer pathogenesis and a mediator of poor outcomes for patients. 詳細を表示
Ikena to discontinue development of IK-930 IK-595 dose escalation continues in RAS and RAF mutant cancers; Encouraging PK and PD profile shown to date Ended first quarter with $157.3 million;...
Ikena to discontinue development of IK-930 IK-595 dose escalation continues in RAS and RAF mutant cancers; Encouraging PK and PD profile shown to date Ended first quarter with $157.3 million;...
Strong financial position with $157.3 million; runway into 2H 2026 IK-930 program on track to deliver clinical update in 2H 2024 IK-595 program continues dose escalation in patients with RAS and...
BOSTON, April 10, 2024 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena,” “Company”), a targeted oncology company forging new territory in patient-directed cancer treatment, today...
IK-930 continues to advance in the clinic now with an optimized formulation with improved pharmacokinetics IK-930 clinical update planned for 2H 2024 including additional data from EHE patients...
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.07 | -4.11764705882 | 1.7 | 1.74 | 1.6 | 98168 | 1.69321181 | CS |
| 4 | -0.01 | -0.609756097561 | 1.64 | 1.7794 | 1.6 | 100050 | 1.67474661 | CS |
| 12 | 0.31 | 23.4848484848 | 1.32 | 1.89 | 1.28 | 263300 | 1.63696498 | CS |
| 26 | 0.26 | 18.9781021898 | 1.37 | 1.89 | 1.22 | 325689 | 1.50115776 | CS |
| 52 | -3.33 | -67.1370967742 | 4.96 | 5.205 | 1.02 | 254049 | 1.79415283 | CS |
| 156 | -8.38 | -83.7162837163 | 10.01 | 17.5 | 1.02 | 168986 | 4.36972105 | CS |
| 260 | -20.77 | -92.7232142857 | 22.4 | 37.61 | 1.02 | 172820 | 6.14271734 | CS |
Monksdream
1週前
Monksdream
2週前
Monksdream
1月前
glenn1919
2月前
Monksdream
5月前
Monksdream
5月前
herbied47
9月前
herbied47
9月前
Tacostocks
9月前
Money hunt
9月前
Tacostocks
9月前
AJ Freely
12月前
Tartiaboy
2年前
TrendTrade2016
2年前
TrendTrade2016
2年前
crudeoil24
3年前
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
